3 US Integrated Energy Stocks to Watch Despite Industry Challenges — Neutral
COP NFG OXY Zacks Investment Research — December 23, 2025Softer crude prices, slowing production growth and mounting renewable demand are making the prospects for the Zacks Oil & Gas US Integrated industry gloomy. ConocoPhillips (COP), Occidental (OXY) and National Fuel (NFG) are well-positioned to survive the challenges.
3 Oil Refining Stocks That Gained More Than 30% in 2025 — Positive
DINO PARR VLO Zacks Investment Research — December 23, 2025VLO, PARR and DINO soared over 30% in 2025. Tight supply and strong execution could keep them worth watching into 2026.
Key Petrobras field hits output pace equivalent to 1 million bpd, sources says — Positive
PBR PBR-A Reuters — December 23, 2025Brazilian state-run oil firm Petrobras' Tupi field briefly reached a production pace this week that, if sustained for a full day, would amount to 1 million barrels, three sources familiar with the matter told Reuters.
ServiceNow agreed to acquire cybersecurity startup Armis for about $7.75 billion in cash in a move intended to take advantage of growing demand for AI security.
Silver Has Crushed the S&P 500 This Year, Here's My Top Pick If The Boom Continues — Positive
CDE 24/7 Wall Street — December 23, 20252025 will surely be remembered as the year that both gold and silver prices exploded.
Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure — Neutral
PRE GlobeNewsWire — December 23, 2025CHARLOTTE, N.C., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced that it has entered into warrant exchange agreements, subject to customary closing conditions, with holders representing approximately 83.4% of its outstanding Class A and Class B warrants, pursuant to a voluntary warrant exchange program designed to simplify the Company's capital structure and materially reduce potential future dilution.
Nvidia and AMD Just Got Some Interesting News About the China Market — Neutral
AMD NVDA The Motley Fool — December 23, 2025In today's video, I discuss recent updates affecting Nvidia (NVDA +1.51%), Advanced Micro Devices (AMD +0.71%), and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special offer link below.
Novo CEO Says Wegovy Pill Is Safe and Will Be Widely Available — Positive
NVO Bloomberg Markets and Finance — December 23, 2025Novo Nordisk President and CEO Mike Doustdar says Christmas has come early with US approval of its Wegovy weight loss pill. He says the company is going "all-in" and they are super excited to be the first to market.
ICL Strengthens Food Ingredients Platform With Bartek Acquisition — Positive
ICL Zacks Investment Research — December 23, 2025ICL Group strikes a two-stage deal to buy Bartek Ingredients, adding food-grade acidulants and boosting its specialty food solutions platform.
FISERV, INC. (FISV) (FI) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by January 5, 2026 — Neutral
FI FISV Newsfile Corp — December 23, 2025Philadelphia, Pennsylvania--(Newsfile Corp. - December 23, 2025) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit against Fiserv, Inc. (NASDAQ: FISV) (NYSE: FI) ("Fiserv" or the "Company") has been filed on behalf of investors who purchased Fiserv shares during the period of July 23, 2025 through October 29, 2025 (the "Class Period"). Investor Deadline: Investors who purchased Fiserv securities during the Class Period may, no later than January 5, 2026, seek to be appointed as a lead plaintiff representative of the class.
Press Release: Sanofi's Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia — Neutral
SNY GlobeNewsWire — December 23, 2025Sanofi's Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ITP Approval based on the LUNA 3 phase 3 study that demonstrated rapid and durable platelet response and improvements in other ITP symptoms ITP is a rare disease of complex immune dysregulation leading to lower platelet counts, bleeding, and reduced quality of life Paris, December 23, 2025 – The European Commission has approved Wayrilz (rilzabrutinib), a novel, oral, reversible, Bruton's tyrosine kinase (BTK) inhibitor, as a new treatment for immune thrombocytopenia …
ServiceNow acquiring cybersecurity startup Armis for nearly $8 billion — Positive
NOW CNBC — December 23, 2025ServiceNow will acquire cybersecurity startup Armis in a $7.75 billion deal expected to close next year. The enterprise software company said the deal will bolster its cybersecurity capabilities in the age of artificial intelligence.
ServiceNow to buy cybersecurity startup Armis for $7.75 billion — Positive
NOW Reuters — December 23, 2025ServiceNow has agreed to buy cybersecurity startup Armis for $7.75 billion in cash, the companies said on Tuesday, as the enterprise software maker looks to attract new customers amid growing risks of cyberattacks.
iPower Enters into Strategic $30 Million Financing Facility to Strengthen Balance Sheet and Launch Digital Asset Treasury — Neutral
IPW GlobeNewsWire — December 23, 2025RANCHO CUCAMONGA, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq: IPW) today announced that it has entered into a $30 million convertible note financing facility to launch its Digital Asset Treasury (“DAT”) strategy as part of a broader crypto strategy designed to position the Company at the intersection of digital assets and real-world commerce, supported by a $30 million convertible note facility from a US-based institutional investor (the “Facility”).
ServiceNow acquires Armis for $7.75 billion as it bets big on cybersecurity for AI — Positive
NOW Market Watch — December 23, 2025The deal expands ServiceNow's reach into cybersecurity as it aims to create an ‘AI control tower.'
Upexi Files Shelf Registration Statement on Form S-3 with the U.S. SEC — Neutral
UPXI GlobeNewsWire — December 23, 2025Announces Plans to Cancel Equity Line Upon S-3 Effectiveness Move to Shelf Registration Statement Enables More Cost-Effective Capital Raising TAMPA, Fla., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ: UPXI) (“Upexi” or the “Company”), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced the filing of a shelf registration statement (“Shelf Registration”) on Form S-3 with the U.S. Securities and Exchange Commission (the “SEC”) on December 22, 2025.
CDT Environmental Technology Reports 2025 Unaudited Interim Financial Results and Provides Business Updates — Neutral
CDTG GlobeNewsWire — December 23, 2025SHENZHEN, China, Dec. 23, 2025 (GLOBE NEWSWIRE) -- CDT Environmental Technology Investment Holdings Limited (Nasdaq: CDTG) (“CDT”, the “Company”, or “we”), a leading provider of waste treatment systems and services throughout China, today reports its unaudited interim financial results for the six months ended June 30, 2025, and provides updates on key business developments. All amounts are expressed in US dollars unless otherwise stated.
Gold near session highs after U.S. durable goods posts -2.2% loss in October — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — December 23, 2025Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
Buffett's $24 Billion Selling Spree: The 6 Stocks Berkshire Hathaway Dumped — Negative
BRK-A BRK-B 24/7 Wall Street — December 23, 2025Investors began to notice that Warren Buffett began being more conservative with the stock market three years ago, and that streak has continued even as the S&P 500 hit new peaks and beyond.
HSBC vs. Barclays: Which Global Bank is Better Positioned for 2026? — Positive
BCS HSBC Zacks Investment Research — December 23, 2025HSBC's Asia-focused revamp and Barclays' U.S. consumer push set the stage for a 2026 showdown between global banking giants. Let's find out which one to buy.